dr. gainor on neoadjuvant checkpoint blockade in nsclc
Published 5 years ago • 51 plays • Length 2:17Download video MP4
Download video MP3
Similar videos
-
1:09
dr. gainor on neoadjuvant use of biomarkers in nonmetastatic lung cancer
-
7:00
expert report on neoadjuvant immune checkpoint inhibitors for nsclc
-
2:32
practical considerations for adjuvant vs. neoadjuvant immunotherapy in nsclc
-
1:10
dr. roland on the rationale for a neoadjuvant checkpoint blockade in sarcoma
-
2:10
dr. gainor discusses the future of egfr nsclc
-
1:54
dr. gainor on the pacific-2 trial in stage iii nsclc
-
29:49
justin gainor talks about immunotherapy as innovation
-
1:17
dr. chaft on investigational neoadjuvant immunotherapy approaches in nsclc
-
11:21
reddet livet med immunterapi
-
6:01
the evolution of immunotherapy in brain tumor treatment
-
12:20
neoadjuvant therapy for cholangiocarcinoma treatment
-
4:35
neoadjuvant checkpoint inhibition in nsclc
-
2:51
neoadjuvant treatment for patients with nsclc - targeted therapies in lung cancer 2023
-
3:09
summary of immunotherapy: justin gainor, md
-
1:55
neoadjuvant chemotherapy shows promise for structure preservation in npnscc: results from ea3163
-
0:30
preview: dr. gainor on pd-l1 testing
-
0:20
preview: dr. gainor on clinical trials
-
4:41
immunotherapy for operable nsclc
-
1:42
managing immune-related adverse events in adjuvant immunotherapy
-
1:26
dr. menter on neoadjuvant immunotherapy in early-stage nsclc
-
2:31
differences in treating lung cancer with adjuvant and neoadjuvant immunotherapy
-
1:00:29
drs. jänne, garon, & yu, discuss the latest #nsclc updates from #ttlc22 - https://bit.ly/355e4dq